Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets

被引:0
|
作者
Endo, T
Ogawa, T
Hamaue, N
Akita, K
Hirafuji, M
Minami, M [1 ]
Blower, PR
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan
[2] SmithKline Beecham Pharmaceut, Strateg Prod Dev, Harlow CM19 5AW, Essex, England
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the influence of granisetron, a 5-HT3 receptor antagonist, on the increase in 5-hydroxytryptamine (5-HT) release induced by cisplatin from the isolated ileum of the ferret, a species known to vomit in response to cisplatin. 2-Methyl-5-MT, a selective 5-HT, receptor agonist, increased the release of 5-HT from the ferret ileum in a concentration-dependent manner within the range of 10(-7) to 10(-6) M . The 5-HT release induced by 2-methyl-5-HT was significantly inhibited by a concomitant perfusion with granisetron (10(-6) M). Cisplatin also increased the 5-HT release from the ferret ileum within the range of 10(-8) to 10(-6) M, in a concentration-dependent manner. Granisetron (10(-6) M) also significantly inhibited the cisplatin-induced 5-HT release. Since the cisplatin-induced 5-HT release was significantly inhibited by tetrodotoxin, the possible involvement of an interneuron pathway in the cisplatin-induced 5-HT release mechanism was suggested in the ileal tissue. It is likely that granisetron inhibited the cisplatin-induced 5-HT release from the gut EC cells by producing blockade of an EC cell 5-HT3 receptor.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 50 条
  • [41] Cyclophosphamide increases 5-hydroxytryptamine release from the isolated ileum of the rat
    Minami, M
    Ogawa, T
    Endo, T
    Hamaue, N
    Hirafuji, M
    Yoshioka, M
    Blower, PR
    Andrews, PLR
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1997, 97 (01) : 13 - 24
  • [42] CHANGES IN NOCICEPTION INDUCED BY A 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONIST
    FASMER, OB
    BERGE, OG
    HOLE, K
    ACTA PHYSIOLOGICA SCANDINAVICA, 1983, 118 (02): : A28 - A28
  • [43] Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine:: the involvement of endogenous 5-hydroxytryptamine
    Tuladhar, BR
    Costall, B
    Naylor, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 136 (01) : 150 - 156
  • [44] VAGOTOMY AND ONDANSETRON (5-HT3 ANTAGONIST) INHIBITED THE INCREASE OF SEROTONIN CONCENTRATION INDUCED BY CYTOTOXIC DRUGS IN THE AREA POSTREMA OF FERRETS
    ENDO, T
    MINAMI, M
    MONMA, Y
    YOSHIOKA, M
    SAITO, H
    PARVEZ, SH
    BIOGENIC AMINES, 1992, 9 (03) : 163 - 175
  • [45] 5-HT3 RECEPTOR ANTAGONISTS INJECTED INTO THE AREA POSTREMA INHIBIT CISPLATIN-INDUCED EMESIS IN THE FERRET
    HIGGINS, GA
    KILPATRICK, GJ
    BUNCE, KT
    JONES, BJ
    TYERS, MB
    BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (01) : 247 - 255
  • [46] ANTIEMETIC EFFECTS OF GR38032F(SN-307), A NEW 5-HT3 ANTAGONIST, ON CISPLATIN-INDUCED AND CYCLOPHOSPHAMIDE-INDUCED EMESIS IN FERRETS
    ENDO, T
    MONMA, Y
    MINAMI, M
    HAMAUE, N
    TAKANO, Y
    NISHIKIORI, M
    SAITO, H
    TOSHIMITSU, Y
    UEKI, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1712 - 1712
  • [47] Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist
    Ozaki, A
    Sukamoto, T
    GENERAL PHARMACOLOGY, 1999, 33 (03): : 283 - 288
  • [48] EFFECTS OF DAU-6215, A NOVEL 5-HYDROXYTRYPTAMINE(3) (5-HT3) ANTAGONIST ON ELECTROPHYSIOLOGICAL PROPERTIES OF THE RAT HIPPOCAMPUS
    PASSANI, MB
    PUGLIESE, AM
    AZZURRINI, M
    CORRADETTI, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) : 695 - 703
  • [49] CHEMICAL MODULATION OF 5-HT3 AND 5-HT4 RECEPTORS AFFECTS THE RELEASE OF 5-HYDROXYTRYPTAMINE FROM THE FERRET AND RAT INTESTINE
    MINAMI, M
    TAMAKAI, H
    OGAWA, T
    ENDO, T
    HAMAUE, N
    HIRAFUJI, M
    YOSHIOKA, M
    BLOWER, PR
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1995, 89 (02) : 131 - 142
  • [50] FOCUS ON GRANISETRON - THE 2ND 5-HT3 RECEPTOR ANTAGONIST APPROVED FOR CHEMOTHERAPY-INDUCED EMESIS
    JAY, GT
    WALLACE, M
    DEFUSCO, P
    HOSPITAL FORMULARY, 1994, 29 (03): : 191 - &